Colin Walsh - 17 Jun 2022 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Tammy Furlong, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
17 Jun 2022
Net transactions value
$0
Form type
4
Filing time
22 Jun 2022, 18:45:28 UTC
Previous filing
24 Jun 2021
Next filing
21 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +15,619 $0.000000 15,619 17 Jun 2022 Common Stock 15,619 $1.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire award will vest on the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on such date.